EP167: How Pharma Can Work With Health Innovators to Improve Outcomes and Strengthen Brands With Stacey Richter and Dave Dierk, Co-Presidents of Aventria Health Group

Stacey is co-president/CEO of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other health care organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient.

Dave is co-president/CEO of Aventria Health Group. He is a 27-year veteran of managed-markets marketing. After working in consumer marketing with AT&T and health care publishing with Elsevier, Dave made the move to medical advertising and communications at KI Lipton, Inc. Subsequently, he became a cofounder of Pinnacle. Dave is an accomplished strategist, providing innovative customer marketing, access, quality, and health intervention solutions for large clients and has directed the development of numerous industry-leading campaigns in primary care and specialty markets. He has supported clients in disease areas that include oncology (Bristol Myers Squibb [BMS], Novartis, Eisai), virology (BMS, Merck & Co.), pharmacy (American Pharmacists Association, Merck, Novartis), and blood disorders (Novo Nordisk), to name a few. Dave has helped more than 15 clients achieve top rankings in their respective categories. He is also an active member of the Pharmacy Quality Alliance.

00:00 The upsides of a partnership between a pharmaceutical company and an innovator.
04:00 “How do we improve patient outcomes?” “How do we improve the efficiency of the healthcare system?” “How do we leverage data?”
06:00 Nuances in health data.
07:15 Attributes that Pharma brings to the table when working with an innovator.
08:00 Building solutions.
11:00 How to make a “win-win” in a brand.
12:30 Growing impacts in a measurable and sustainable way.
12:50 Shared objectives.
14:00 Historical pharmaceutical business models.
17:40 What a successful pilot looks like.
21:45 Structuring pilot programs like minimal viable products.
23:40 Build something that will have a high degree of success or confidence for success.
23:50 “The object of the game would be to mid-course correct.”
25:30 “There has to be universal learnings that we’re picking up.”
25:50 The difference between a pilot and a study.
26:13 “You have to determine feasibility right upfront.”
26:36 Set success metrics.
27:45 “If you haven’t specified what success looks like, it’s really hard to be successful.”
33:45 You can learn more about Aventria Health Group at aventriahealth.com or by emailing david.dierk@aventriahealth.com.